Literature DB >> 6411203

Parathyroid hormone and 25-hydroxyvitamin D concentrations in sick and normal elderly people.

M M Petersen, R S Briggs, M A Ashby, R I Reid, M R Hall, P J Wood, B E Clayton.   

Abstract

Serum 25-hydroxyvitamin D and immunoreactive parathyroid hormone concentrations were measured in normal elderly subjects living at home and in sick elderly patients in hospital. Normal old people tended to have high 25-hydroxyvitamin D and low parathyroid hormone concentrations; in the sick elderly this pattern was reversed. The raised serum parathyroid hormone concentrations in the sick elderly were not due to poor renal function and may have been a response to vitamin D deficiency. A high serum parathyroid hormone concentration in an elderly patient must be interpreted in the light of the patient's general health and nutritional state. Caution is needed in diagnosing primary hyperparathyroidism in this age group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411203      PMCID: PMC1548439          DOI: 10.1136/bmj.287.6391.521

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Influence of reagent quality and reaction conditions on the determination of serum albumin by the bromcresol green dye-binding method.

Authors:  K Spencer; C P Price
Journal:  Ann Clin Biochem       Date:  1977-03       Impact factor: 2.057

Review 2.  Normal values for sixteen blood constituents in the elderly.

Authors:  R G Leask; G R Andrews; F I Caird
Journal:  Age Ageing       Date:  1973-02       Impact factor: 10.668

3.  Increases in immunoreactive parathyroid hormone with age.

Authors:  P S Wiske; S Epstein; N H Bell; S F Queener; J Edmondson; C C Johnston
Journal:  N Engl J Med       Date:  1979-06-21       Impact factor: 91.245

4.  Vitamin-D status in long-stay geriatric patients.

Authors:  D Corless; B J Boucher; R D Cohen; M Beer; S P Gupta
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

5.  25-hydroxy-vitamin D, diet and sunlight exposure in patients admitted to a geriatric unit.

Authors:  A S Nayal; W J MacLennan; J C Hamilton; P Rose; M Kong
Journal:  Gerontology       Date:  1978       Impact factor: 5.140

6.  Serum parathyroid hormone levels and serum calcium levels from birth to senescence.

Authors:  B S Roof; C F Piel; J Hansen; H H Fudenberg
Journal:  Mech Ageing Dev       Date:  1976 Jul-Aug       Impact factor: 5.432

7.  The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure.

Authors:  G M Berlyne; J Ben-Ari; A Kushelevsky; A Idelman; D Galinsky; M Hirsch; R Shainkin; R Yagil; M Zlotnik
Journal:  Q J Med       Date:  1975-07

8.  Sensitivity of the antibovine parathyroid hormone serum 211/32 to synthetic fragments of human parathyroid hormone.

Authors:  L E Mallette
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

9.  Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

Authors:  H Heath; S F Hodgson; M A Kennedy
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

10.  Vitamin D status of residents of an old people's home and long-stay patients.

Authors:  D Corless; S P Gupta; D A Sattar; S Switala; B J Boucher
Journal:  Gerontology       Date:  1979       Impact factor: 5.140

View more
  3 in total

1.  Effect of ovariectomy on bone histology and plasma parameters of bone metabolism in nulliparous and multiparous sows.

Authors:  K E Scholz-Ahrens; G Delling; P W Jungblut; E Kallweit; C A Barth
Journal:  Z Ernahrungswiss       Date:  1996-03

2.  Parathyroid hormone, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration in elderly patients.

Authors:  P Oster; T Müller; H Schmidt-Gayk; G Schlierf
Journal:  Klin Wochenschr       Date:  1990-04-17

3.  Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy.

Authors:  P S Jowell; S Epstein; F Ismail; B Hollis; I R Schwartz
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.